Company Data

ProKidney Corp.

Ticker
PROK
Current Price
$1.5 -1.32%
Market Cap
$437.5M
Price Target
Refer to Report
Volume
320.8K
52wk Range
$1.34 - $4.44
Advanced Market Data

Overview

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient’s own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient’s own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy